Gastroresistant Formulation

Gastroresistant Formulation is a pharmaceutical dosage form designed to remain intact in the acidic environment of the stomach and to release its active ingredient only upon reaching the higher pH of the intestinal tract, thereby preventing gastric degradation and minimizing gastric irritation.

24

Publications

824

Citations

156

Authors

60

Institutions

Publications per year

2017–2026

11

Variants

Enteric Dosage FormEnteric FormulationGastroresistant Dosage Form

Publications

24

1–5 of 24

Authors

156

  1. MS
    Małgorzata Sznitowska

    Gdańsk Medical University, Poland

    2 publications · 22 citations

    2

    h-index

  2. LN
    Lígia Nunes de Morais Ribeiro

    Universidade Estadual de Campinas (UNICAMP), Brazil

    1 publications · 31 citations

    1

    h-index

  3. RC
    Roberto Comparelli

    University of Bari Aldo Moro, Italy

    1 publications · 59 citations

    1

    h-index

  4. WW
    Werner Weitschies

    Universität Greifswald, Germany

    1 publications · 10 citations

    1

    h-index

  5. PA
    Paulo A.S. Mourão

    Universidade Federal do Rio de Janeiro, Brazil

    1 publications · 41 citations

    1

    h-index

1–5 of 156

Venues

  1. Drug Development and Industrial Pharmacy

    4 publications · 112 citations

    4

    h-index

  2. ˜Die œPharmazie

    2 publications · 22 citations

    2

    h-index

  3. Pharmaceutics

    2 publications · 80 citations

    2

    h-index

  4. Journal of Clinical Gastroenterology

    1 publications · 54 citations

    1

    h-index

  5. European Journal of Pharmaceutical Sciences

    1 publications · 16 citations

    1

    h-index

1–5